glp-1 agonists names Receptor GLP-1 receptor agonists | How

46 Drug-Drug Interactions: Saxagliptin is a strong CYP3A4 inhibitor, so its labeling recommends limiting saxagliptin to 2.5 mg daily in patients taking other strong CYP3A4 inhibitors, such as ketoconazole, based on the risk of increased saxagliptin levels

The Current State of GLP-1 Drugs 2023 research from IQVIA has shown that demand for GLP-1 drugs has accelerated since early 2020, corresponding to the launches of Ozempic, Wegovy and Mounjaro variations

Their primary ingredient is Semaglutide, which is the synthetic form of the hormone Glucagon-like-peptide-1 (aka GLP-1)

Another triple agonist (HM15211) is undergoing phase 1 clinical trials with no published data so far

TFEB, transcription factor EB

Doesnt go up as your dose does